Company Filing History:
Years Active: 2011
Title: Albert Wong: Innovator in Parenteral Formulations
Introduction
Albert Wong is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for parenteral administration. His work focuses on addressing conditions mediated by abnormal cell proliferation.
Latest Patents
Albert Wong holds a patent for "Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones." This patent provides formulations for the parenteral administration of amino substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones and their sodium and potassium salts. These formulations are designed for the prevention and treatment of various medical conditions. The compositions include an effective amount of the compound along with at least 50% by weight of a water-soluble polymer, such as polyethylene glycol (PEG) and polyvinylpyrrolidone (PVP).
Career Highlights
Albert Wong is currently associated with Onconova Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in formulation development has positioned him as a valuable asset in the company.
Collaborations
Throughout his career, Albert has collaborated with esteemed colleagues, including Stanley Charles Bell and Manoj Maniar. These collaborations have further enhanced
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.